DG
MRNA icon

DMC Group’s Moderna MRNA Stock Holding History

DMC Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,859
Closed -$325K – 135
2024
Q3 		$325K Sell
4,859
-4,554
-48% -$418K 0.26% 105
2024
Q2 		$1.12M Buy
9,413
+827
+10% +$105K 0.96% 32
2024
Q1 		$915K Buy
8,586
+870
+11% +$87.7K 0.79% 43
2023
Q4 		$767K Buy
7,716
+927
+14% +$78K 0.73% 47
2023
Q3 		$701K Buy
6,789
+887
+15% +$98.9K 0.66% 52
2023
Q2 		$717K Buy
5,902
+690
+13% +$92K 0.72% 48
2023
Q1 		$831K Buy
5,212
+82
+2% +$13.5K 0.84% 38
2022
Q4 		$918K Buy
5,130
+1,189
+30% +$194K 1.04% 24
2022
Q3 		$477K Buy
3,941
+2,019
+105% +$306K 0.58% 50
2022
Q2 		$283K Buy
+1,922
New +$275K 0.34% 84

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

DMC Group's MRNA Position: Q4 2024 in Review

DMC Group sold out of Moderna (MRNA) in Q4 2024, closing a stake of 4,859 shares — an estimated $325K sold.

DMC Group first reported a position in MRNA in Q2 2022 and held it in 10 quarters. The position peaked at $1.12M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • DMC Group reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • DMC Group sold 4,859 Moderna shares in Q4 2024, an estimated $325K.
  • DMC Group first reported a position in Moderna in Q2 2022 and held it in 10 quarters.
  • DMC Group's Moderna position peaked at $1.12M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on DMC Group's 13F filing for Q4 2024, filed 23 Jan 2025.